About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Investor Centre
- Investor Centre
- News & ASX Announcements
Contact

Hit enter to search or ESC to close

News & ASX Announcements

Female scientist looking through a a microscope

Recent Posts

Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
Change of Company Name and ASX Code
May 24, 2019
2019 Annual General Meeting Results
May 22, 2019

Categories

Analyst Coverage
Company Announcement
Company Report
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Company Announcement

Ashland Purchases Manufacturing Rights for VitalET and TPM

June 20, 2019August 28, 2019

Company Announcement

Change of Company Name and ASX Code

May 24, 2019August 28, 2019

Company Announcement

2019 Annual General Meeting Results

May 22, 2019August 28, 2019

Company Announcement

Phosphagenics and Mylan Agree Settlement

December 19, 2018

Company Announcement

Voluntary Withdrawal from OTCQX

December 3, 2018

Company Announcement

Receipt of R&D Tax Incentive

November 27, 2018

Company Announcement

Phosphagenics Arbitration Award Issued

November 12, 2018

Company Announcement

Receipt of R&D Tax Incentive

November 8, 2018

Company Announcement

Phosphagenics Receives Further Arbitration Process Update

October 23, 2018

1
2
3
→

Stay Posted

Stay informed about our latest news and developments.

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- News & ASX Announcements

© Copyright 2019 Avecho Biotechnology Ltd.